iSpecimen (NASDAQ:ISPC) & NewGenIvf Group (NASDAQ:NIVF) Financial Analysis

Earnings & Valuation

This table compares iSpecimen and NewGenIvf Group”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iSpecimen	$9.29 million	0.73	-$12.50 million	($9.51)	-0.13
NewGenIvf Group	$5.43 million	0.74	-$520,000.00	N/A	N/A

NewGenIvf Group has lower revenue, but higher earnings than iSpecimen.

Volatility and Risk

iSpecimen has a beta of 1.8, suggesting that its share price is 80% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of -0.07, suggesting that its share price is 107% less volatile than the S&P 500.

Institutional and Insider Ownership

13.6% of iSpecimen shares are owned by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are owned by institutional investors. 12.2% of iSpecimen shares are owned by insiders. Comparatively, 31.8% of NewGenIvf Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares iSpecimen and NewGenIvf Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
iSpecimen	-172.48%	-395.15%	-121.72%
NewGenIvf Group	N/A	N/A	N/A

Summary

NewGenIvf Group beats iSpecimen on 7 of the 9 factors compared between the two stocks.

About iSpecimen

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

About NewGenIvf Group

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand.